Foster Dykema Cabot & Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Hold
5,153
0.08% 43
2026
Q1
$1.26M Hold
5,153
0.08% 42
2025
Q4
$1.07M Sell
5,153
-1,261
-20% -$249K 0.07% 44
2025
Q3
$1.19M Buy
6,414
+902
+16% +$155K 0.08% 47
2025
Q2
$842K Buy
5,512
+800
+17% +$123K 0.06% 58
2025
Q1
$781K Sell
4,712
-409
-8% -$64K 0.06% 56
2024
Q4
$741K Sell
5,121
-603
-11% -$93.4K 0.06% 63
2024
Q3
$928K Buy
5,724
+912
+19% +$145K 0.08% 50
2024
Q2
$703K Buy
4,812
+230
+5% +$34.2K 0.06% 51
2024
Q1
$725K Buy
4,582
+25
+0.5% +$3.98K 0.07% 48
2023
Q4
$714K Buy
+4,557
New +$699K 0.08% 46

Other funds holding JNJ

Foster Dykema Cabot & Partners's JNJ Position: Q2 2026 in Review

Foster Dykema Cabot & Partners held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 5,153 shares worth $1.31M. The position accounts for 0.08% of the portfolio, ranked #43.

Foster Dykema Cabot & Partners first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,678 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Foster Dykema Cabot & Partners held 5,153 shares of Johnson & Johnson worth $1.31M as of Q2 2026.
  • Foster Dykema Cabot & Partners left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.08% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #43 holding.
  • Foster Dykema Cabot & Partners first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.